Patent Assignment
Reel/Frame 028947/0938
Assignment of Assignor's Interest
Recorded: 2012-09-12
Pages: 2
Assignor
STERN, WILLIAM
Executed: 2001-02-08
Assignee
UNIGENE LABORATORIES INC.
110 LITTLE FALLS ROAD, FAIRFIELD, NEW JERSEY, 07004-2193
Covered Properties
(2)
Nasal Calcitonin Formulation
Patent:
40,812 →
Application:
10/774,358 →
Nasal Calcitonin Formulations
Patent:
43,580 →
Application:
12/459,385 →
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Oct 3, 2008
From: UNIGENE LABORATORIES, INC.
To: VICTORY PARK MANAGEMENT, LLC
Reel/Frame 021630/0352 →
Security Agreement
Oct 4, 2012
From: UNIGENE LABORATORIES, INC.
To: VICTORY PARK MANAGEMENT, LLC, AS COLLATERAL AGENT
Reel/Frame 029074/0689 →
Assignment of Assignor's Interest
Jul 23, 2013
From: UNIGENE LABORATORIES, INC.
To: UGP THERAPEUTICS, INC.
Reel/Frame 030856/0340 →
Assignment of Assignor's Interest
Jul 19, 2016
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 039184/0797 →
Corrective Assignment to Correct the Nature of Conveyance Previously Recorded on Reel 039184 Frame 0797. Assignor(S) Hereby Confirms the Nunc Pro Tunc Assignment Effective 02/01/2016.
Aug 15, 2016
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 039682/0212 →
Release of Security Interest
Aug 8, 2019
From: VICTORY PARK MANAGEMENT, LLC
To: UNIGENE LABORATORIES, INC.
Reel/Frame 050000/0799 →
Release of Security Interest
Aug 8, 2019
From: VICTORY PARK MANAGEMENT, LLC
To: UNIGENE LABORATORIES, INC.
Reel/Frame 050000/0762 →
Security Interest
Aug 26, 2019
From: ENTERIS BIOPHARMA, INC.
To: CADENCE BANK, N.A.
Reel/Frame 050174/0428 →
Release of Security Interest
Jun 28, 2023
From: CADENCE BANK, A MISSISSIPPI BANK AND SUCCESSOR BY MERGER TO CADENCE BANK, N.A., A NATIONAL BANKING ASSOCIATION, AS AGENT
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 064149/0741 →